Nevertheless, a comparison can be made concerning the number of men referred for MRI, as PSA ≥ 3 ng/ml serves as a commonly used indication and is recommended as the primary screening test for prostate cancer by both the European Association of Urology and the American Urological Association [19], [20]. This evidence concerns the gene KLK3 and prostate carcinoma.